Copyright Reports & Markets. All rights reserved.

Global Amebiasis Treatment Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Amebiasis Treatment Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Metronidazole
      • 1.2.2 Paromomycin
      • 1.2.3 Tinidazole
      • 1.2.4 Other
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospital
      • 1.3.2 Pharmacy
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2013-2023)
        • 1.4.1.2 Canada Market States and Outlook (2013-2023)
        • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2013-2023)
        • 1.4.2.2 France Market States and Outlook (2013-2023)
        • 1.4.2.3 UK Market States and Outlook (2013-2023)
        • 1.4.2.4 Russia Market States and Outlook (2013-2023)
        • 1.4.2.5 Italy Market States and Outlook (2013-2023)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2013-2023)
        • 1.4.3.2 Japan Market States and Outlook (2013-2023)
        • 1.4.3.3 Korea Market States and Outlook (2013-2023)
        • 1.4.3.4 India Market States and Outlook (2013-2023)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
        • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
        • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
        • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Dr. Reddy’s Laboratories
      • 2.1.1 Business Overview
      • 2.1.2 Amebiasis Treatment Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Dr. Reddy’s Laboratories Amebiasis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.2 Mission Pharmacal
      • 2.2.1 Business Overview
      • 2.2.2 Amebiasis Treatment Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Mission Pharmacal Amebiasis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.3 Aceto Corporation
      • 2.3.1 Business Overview
      • 2.3.2 Amebiasis Treatment Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Aceto Corporation Amebiasis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.4 Mylan Pharmaceuticals
      • 2.4.1 Business Overview
      • 2.4.2 Amebiasis Treatment Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Mylan Pharmaceuticals Amebiasis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.5 Impax Laboratories
      • 2.5.1 Business Overview
      • 2.5.2 Amebiasis Treatment Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Impax Laboratories Amebiasis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.6 Pfizer
      • 2.6.1 Business Overview
      • 2.6.2 Amebiasis Treatment Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Pfizer Amebiasis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.7 Sanofi
      • 2.7.1 Business Overview
      • 2.7.2 Amebiasis Treatment Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Sanofi Amebiasis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.8 Lupin Pharmaceuticals
      • 2.8.1 Business Overview
      • 2.8.2 Amebiasis Treatment Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Lupin Pharmaceuticals Amebiasis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.9 Glenmark Pharmaceuticals
      • 2.9.1 Business Overview
      • 2.9.2 Amebiasis Treatment Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Glenmark Pharmaceuticals Amebiasis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.10 Sun Pharmaceutical
      • 2.10.1 Business Overview
      • 2.10.2 Amebiasis Treatment Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Sun Pharmaceutical Amebiasis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    • 2.11 Heritage Pharmaceuticals
      • 2.11.1 Business Overview
      • 2.11.2 Amebiasis Treatment Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Heritage Pharmaceuticals Amebiasis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    3 Global Amebiasis Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Amebiasis Treatment Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Amebiasis Treatment Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Amebiasis Treatment Manufacturer Market Share in 2017
      • 3.3.2 Top 6 Amebiasis Treatment Manufacturer Market Share in 2017
    • 3.4 Market Competition Trend

    4 Global Amebiasis Treatment Market Analysis by Regions

    • 4.1 Global Amebiasis Treatment Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Amebiasis Treatment Sales and Market Share by Regions (2013-2018)
      • 4.1.2 Global Amebiasis Treatment Revenue and Market Share by Regions (2013-2018)
    • 4.2 North America Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 4.3 Europe Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 4.4 Asia-Pacific Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 4.5 South America Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 4.6 Middle East and Africa Amebiasis Treatment Sales and Growth Rate (2013-2018)

    5 North America Amebiasis Treatment by Countries

    • 5.1 North America Amebiasis Treatment Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Amebiasis Treatment Sales and Market Share by Countries (2013-2018)
      • 5.1.2 North America Amebiasis Treatment Revenue and Market Share by Countries (2013-2018)
    • 5.2 United States Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 5.3 Canada Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 5.4 Mexico Amebiasis Treatment Sales and Growth Rate (2013-2018)

    6 Europe Amebiasis Treatment by Countries

    • 6.1 Europe Amebiasis Treatment Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Amebiasis Treatment Sales and Market Share by Countries (2013-2018)
      • 6.1.2 Europe Amebiasis Treatment Revenue and Market Share by Countries (2013-2018)
    • 6.2 Germany Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 6.3 UK Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 6.4 France Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 6.5 Russia Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 6.6 Italy Amebiasis Treatment Sales and Growth Rate (2013-2018)

    7 Asia-Pacific Amebiasis Treatment by Countries

    • 7.1 Asia-Pacific Amebiasis Treatment Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Amebiasis Treatment Sales and Market Share by Countries (2013-2018)
      • 7.1.2 Asia-Pacific Amebiasis Treatment Revenue and Market Share by Countries (2013-2018)
    • 7.2 China Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 7.3 Japan Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 7.4 Korea Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 7.5 India Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 7.6 Southeast Asia Amebiasis Treatment Sales and Growth Rate (2013-2018)

    8 South America Amebiasis Treatment by Countries

    • 8.1 South America Amebiasis Treatment Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Amebiasis Treatment Sales and Market Share by Countries (2013-2018)
      • 8.1.2 South America Amebiasis Treatment Revenue and Market Share by Countries (2013-2018)
    • 8.2 Brazil Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 8.3 Argentina Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 8.4 Colombia Amebiasis Treatment Sales and Growth Rate (2013-2018)

    9 Middle East and Africa Amebiasis Treatment by Countries

    • 9.1 Middle East and Africa Amebiasis Treatment Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Amebiasis Treatment Sales and Market Share by Countries (2013-2018)
      • 9.1.2 Middle East and Africa Amebiasis Treatment Revenue and Market Share by Countries (2013-2018)
    • 9.2 Saudi Arabia Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 9.3 UAE Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 9.4 Egypt Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 9.5 Nigeria Amebiasis Treatment Sales and Growth Rate (2013-2018)
    • 9.6 South Africa Amebiasis Treatment Sales and Growth Rate (2013-2018)

    10 Global Amebiasis Treatment Market Segment by Type

    • 10.1 Global Amebiasis Treatment Sales, Revenue and Market Share by Type (2013-2018)
      • 10.1.1 Global Amebiasis Treatment Sales and Market Share by Type (2013-2018)
      • 10.1.2 Global Amebiasis Treatment Revenue and Market Share by Type (2013-2018)
    • 10.2 Metronidazole Sales Growth and Price
      • 10.2.1 Global Metronidazole Sales Growth (2013-2018)
      • 10.2.2 Global Metronidazole Price (2013-2018)
    • 10.3 Paromomycin Sales Growth and Price
      • 10.3.1 Global Paromomycin Sales Growth (2013-2018)
      • 10.3.2 Global Paromomycin Price (2013-2018)
    • 10.4 Tinidazole Sales Growth and Price
      • 10.4.1 Global Tinidazole Sales Growth (2013-2018)
      • 10.4.2 Global Tinidazole Price (2013-2018)
    • 10.5 Other Sales Growth and Price
      • 10.5.1 Global Other Sales Growth (2013-2018)
      • 10.5.2 Global Other Price (2013-2018)

    11 Global Amebiasis Treatment Market Segment by Application

    • 11.1 Global Amebiasis Treatment Sales Market Share by Application (2013-2018)
    • 11.2 Hospital Sales Growth (2013-2018)
    • 11.3 Pharmacy Sales Growth (2013-2018)

    12 Amebiasis Treatment Market Forecast (2018-2023)

    • 12.1 Global Amebiasis Treatment Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Amebiasis Treatment Market Forecast by Regions (2018-2023)
      • 12.2.1 North America Amebiasis Treatment Market Forecast (2018-2023)
      • 12.2.2 Europe Amebiasis Treatment Market Forecast (2018-2023)
      • 12.2.3 Asia-Pacific Amebiasis Treatment Market Forecast (2018-2023)
      • 12.2.4 South America Amebiasis Treatment Market Forecast (2018-2023)
      • 12.2.5 Middle East and Africa Amebiasis Treatment Market Forecast (2018-2023)
    • 12.3 Amebiasis Treatment Market Forecast by Type (2018-2023)
      • 12.3.1 Global Amebiasis Treatment Sales Forecast by Type (2018-2023)
      • 12.3.2 Global Amebiasis Treatment Market Share Forecast by Type (2018-2023)
    • 12.4 Amebiasis Treatment Market Forecast by Application (2018-2023)
      • 12.4.1 Global Amebiasis Treatment Sales Forecast by Application (2018-2023)
      • 12.4.2 Global Amebiasis Treatment Market Share Forecast by Application (2018-2023)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Amebiasis is an infection of the intestine caused by a parasite Entamoeba Histolytica. Symptoms of this disease include loose stool, abdominal cramping, and stomach pain. 

      Scope of the Report:
      The worldwide market for Amebiasis Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
      This report focuses on the Amebiasis Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Dr. Reddy’s Laboratories
      Mission Pharmacal
      Aceto Corporation
      Mylan Pharmaceuticals
      Impax Laboratories
      Pfizer
      Sanofi
      Lupin Pharmaceuticals
      Glenmark Pharmaceuticals
      Sun Pharmaceutical
      Heritage Pharmaceuticals

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Metronidazole
      Paromomycin
      Tinidazole
      Other

      Market Segment by Applications, can be divided into
      Hospital
      Pharmacy

      There are 15 Chapters to deeply display the global Amebiasis Treatment market.
      Chapter 1, to describe Amebiasis Treatment Introduction, product scope, market overview, market opportunities, market risk, market driving force;
      Chapter 2, to analyze the top manufacturers of Amebiasis Treatment, with sales, revenue, and price of Amebiasis Treatment, in 2016 and 2017;
      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
      Chapter 4, to show the global market by regions, with sales, revenue and market share of Amebiasis Treatment, for each region, from 2013 to 2018;
      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
      Chapter 12, Amebiasis Treatment market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
      Chapter 13, 14 and 15, to describe Amebiasis Treatment sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

      Buy now